Literature DB >> 2287929

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia.

M S Buchsbaum1.   

Abstract

Positron emission tomography studies with fluorodeoxyglucose in patients with schizophrenia are reviewed and findings in the frontal lobes, basal ganglia, and temporal lobes summarized from more than 20 published studies. Despite methodological and clinical population differences between studies, most reports indicate that patients with schizophrenia are more likely to be low in these areas than in the occipital lobe, cerebellum, or in white matter. This is consistent with blood flow and some neuroanatomical findings. Cluster analysis on our own sample suggests that patients may be low in all three areas rather than a pattern of three distinct clusters. Further study of individual symptom differences, medication effects, and of psychophysical tasks salient for these brain areas is indicated.

Entities:  

Mesh:

Year:  1990        PMID: 2287929     DOI: 10.1093/schbul/16.3.379

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  24 in total

1.  Picturing neuroscience research through a human rights lens: imaging first-episode schizophrenic treatment-naive individuals.

Authors:  Marleen Eijkholt; James A Anderson; Judy Illes
Journal:  Int J Law Psychiatry       Date:  2012-02-02

Review 2.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

3.  The ability to produce express saccades as a function of gap interval among schizophrenia patients.

Authors:  B A Clementz
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

Review 4.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Study of childhood onset schizophrenia (COS) using SPECT and neuropsychological assessment.

Authors:  Savita Malhotra; Nitin Gupta; Anish Bhattacharya; Mehak Kapoor
Journal:  Indian J Psychiatry       Date:  2006-10       Impact factor: 1.759

6.  Atrophy of basal ganglia nuclei and negative symptoms in temporal lobe epilepsy.

Authors:  Elizabeth K Geary; Michael Seidenberg; Bruce Hermann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

7.  Smooth pursuit eye tracking dysfunction in schizophrenia: subcortical implications.

Authors:  R T Pivik
Journal:  J Psychiatry Neurosci       Date:  1991-09       Impact factor: 6.186

8.  Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine.

Authors:  Nurith Amitai; Susan Powell; Martin Weber; Neal R Swerdlow; Jared W Young
Journal:  Cogn Affect Behav Neurosci       Date:  2015-12       Impact factor: 3.282

Review 9.  Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.

Authors:  David A Lewis; David W Volk; Takanori Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2003-12-09       Impact factor: 4.530

10.  Cognitive correlates of schizophrenia signs and symptoms: II. Emotional disturbances.

Authors:  Howard Berenbaum; John G Kerns; Laura L Vernon; Jose J Gomez
Journal:  Psychiatry Res       Date:  2008-04-18       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.